Applied Therapeutics Inc. - 10-K filing on 2022-03-10

INVESTMENTS (Tables)

12 Months Ended

Dec. 31, 2021

The following tables provide the Company’s marketable securities by security type (in thousands):


	As of December 31, 2021								As of December 31, 2020
			Gross		Gross						Gross		Gross
			Unrealized		Unrealized		Estimated				Unrealized		Unrealized		Estimated
(in thousands)	Cost		Gains		Losses		Fair Value		Cost		Gains		Losses		Fair Value
US government agency debt security	$	27,042	$	1	$	(108)	$	26,935	$	39,475	$	11	$	(123)	$	39,363
Total	$	27,042	$	1	$	(108)	$	26,935	$	39,475	$	11	$	(123)	$	39,363

Contractual maturities of the Company’s marketable securities are summarized as follows (in thousands):


	As of December 31, 2021
	Securities in an unrealized loss position less than 12 months				Securities in an unrealized loss position greater than 12 months				Total
	Unrealized		Estimated		Unrealized		Estimated		Unrealized		Estimated
(in thousands)	Losses		Fair Value		Losses		Fair Value		Losses		Fair Value
US government agency debt security	$	(108)	$	17,696	$	—	$	—	$	(108)	$	17,696
Total	$	(108)	$	17,696	$	—	$	—	$	(108)	$	17,696


	As of December 31, 2020
	Securities in an unrealized loss position less than 12 months				Securities in an unrealized loss position greater than 12 months				Total
	Unrealized		Estimated		Unrealized		Estimated		Unrealized		Estimated
(in thousands)	Losses		Fair Value		Losses		Fair Value		Losses		Fair Value
US government agency debt security	$	(123)	$	14,073	$	—	$	—	$	(123)	$	14,073
Total	$	(123)	$	14,073	$	—	$	—	$	(123)	$	14,073